|
TROVE2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.363900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.963000E-01 |
| Normal-vs-Stage2 |
6.185600E-01 |
| Normal-vs-Stage3 |
9.095600E-02 |
| Normal-vs-Stage4 |
3.878300E-03 |
| Stage1-vs-Stage2 |
9.750800E-01 |
| Stage1-vs-Stage3 |
3.132800E-01 |
| Stage1-vs-Stage4 |
2.298300E-02 |
| Stage2-vs-Stage3 |
6.231400E-01 |
| Stage2-vs-Stage4 |
3.636000E-01 |
| Stage3-vs-Stage4 |
4.994800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.527220E-01 |
| Normal-vs-AfricanAmerican |
1.795700E-04 |
| Normal-vs-Asian |
7.565000E-01 |
| Caucasian-vs-AfricanAmerican |
1.640520E-03 |
| Caucasian-vs-Asian |
5.727800E-01 |
| AfricanAmerican-vs-Asian |
3.194000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.887600E-02 |
| Normal-vs-Female |
2.414000E-01 |
| Male-vs-Female |
5.014200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.377550E-01 |
| Normal-vs-Age(41-60Yrs) |
2.470800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.870500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.853600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.027400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.735000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.289200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.581200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.171800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.091800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.374000E-01 |
| Normal-vs-Grade 2 |
9.491800E-01 |
| Normal-vs-Grade 3 |
3.577400E-03 |
| Normal-vs-Grade 4 |
3.393800E-04 |
| Grade 1-vs-Grade 2 |
6.690000E-01 |
| Grade 1-vs-Grade 3 |
5.118200E-02 |
| Grade 1-vs-Grade 4 |
1.252300E-02 |
| Grade 2-vs-Grade 3 |
4.524700E-03 |
| Grade 2-vs-Grade 4 |
3.996500E-04 |
| Grade 3-vs-Grade 4 |
1.333390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.349800E-01 |
| Normal-vs-ccB subtype |
3.294400E-02 |
| ccA subtype-vs-ccB subtype |
3.916600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.952810E-01 |
| Normal-vs-N1 |
5.455000E-01 |
| N0-vs-N1 |
8.975000E-01 |
|
|
